ScienceGate Book Chapters

JOURNAL ARTICLE

Late Administration of Tocilizumab for Severe COVID-19 Pneumonia

Pratik Modi Stan Houston Sohail Ejaz Bradley Boldizar B. Russelll

Year: 2025 Journal: American Journal of Respiratory and Critical Care Medicine Vol: 211 (Abstracts)Pages: A6757-A6757 Publisher: American Thoracic Society

DOI: 10.1164/ajrccm.2025.211.abstracts.a6757

Get Full-Text PDF Get Analytical Report

Keywords:

Tocilizumab Medicine Coronavirus disease 2019 (COVID-19) Pneumonia 2019-20 coronavirus outbreak Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Betacoronavirus Administration (probate law) Virology Coronavirus Infections Intensive care medicine Immunology Internal medicine Outbreak Rheumatoid arthritis Infectious disease (medical specialty)

Metrics

1

Cited By

4.40

FWCI (Field Weighted Citation Impact)

0

Refs

0.83

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Citation History

Topics

COVID-19 Clinical Research Studies

Health Sciences → Medicine → Infectious Diseases

SARS-CoV-2 and COVID-19 Research

Health Sciences → Medicine → Infectious Diseases

Long-Term Effects of COVID-19

Health Sciences → Medicine → Neurology

Related Documents

JOURNAL ARTICLE

Tocilizumab for severe COVID-19 pneumonia

Jean‐Jacques Mourad Philippe Azria

Journal: The Lancet Rheumatology Year: 2020 Vol: 2 (11)Pages: e659-e659

JOURNAL ARTICLE

Tocilizumab for severe COVID-19 pneumonia

Salvatore Piano Roberto Vettor Paolo Angeli Gaetano Paride Arcidiacono Devis Benfaremo Silvia Bettini Benedetta Maria Bonora Giovanni Bucca Anna Maria Cattelan Lorenzo Cerruti Andrea Dalbeni V. Framba Anna Maria Carvalhas Gabrielli Carmine Gambino Francesca Ghirardini Umberto Gnudi MM Luchetti Alessandro Mantovani Sara Mareso Maria Cristina Marini Andréa Martini Massimo Mattioli Luciano Mucci Giampaolo Perna Fabio Presotto Caterina Sensi Roberto Serra F Soliani Roberta Stupia Elia Vettore Mirko Zoncapè

Journal: The Lancet Rheumatology Year: 2020 Vol: 2 (11)Pages: e659-e660

JOURNAL ARTICLE

Tocilizumab for severe COVID-19 pneumonia

Brian J. Lipworth Rory Chan Chris RuiWen Kuo

Journal: The Lancet Rheumatology Year: 2020 Vol: 2 (11)Pages: e660-e660

JOURNAL ARTICLE

Tocilizumab for severe COVID-19 pneumonia – Authors' reply

Giovanni Guaraldi Marianna Meschiari Jovana Milić Alessandro Cozzi‐Lepri Cristina Mussini

Journal: The Lancet Rheumatology Year: 2020 Vol: 2 (11)Pages: e660-e661

JOURNAL ARTICLE

Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia

Iván O. Rosas Norbert Bräu Michael R. Waters Ronaldo C. Go Bradley D. Hunter Sanjay Bhagani Daniel J. Skiest Mariam Aziz Nichola Cooper Ivor S. Douglas Sinisa Savic Taryn Youngstein Lorenzo Del Sorbo Antonio Cubillo Gracián David J. De La Zerda Andrew Ustianowski Min Bao Sophie Dimonaco Emily Graham Balpreet Matharu Helen Spotswood Larry Tsai Atul Malhotra

Journal: New England Journal of Medicine Year: 2021 Vol: 384 (16)Pages: 1503-1516